[1]
Bunick, C., Bhatia, N., Del Rosso, J., Draelos, Z., Eichenfield, L., Kircik, L., Lebwohl, M., Gooderham, M., Green, L., Hebert, A., Vender, R., Zirwas, M., Simpson, E., Stein Gold, L., Seal, M., Snyder, S., Osborne, D., Burnett, P., Higham, R., Chu, D. and Berk, D. 2024. Investigator- and Patient-Rated Local Tolerability in Phase 3 Trials of Topical Roflumilast in Patients With Psoriasis, Seborrheic Dermatitis, and Atopic Dermatitis. SKIN The Journal of Cutaneous Medicine. 8, 1 (Jan. 2024), s309. DOI:https://doi.org/10.25251/skin.8.supp.309.